Geben Sie eine Aktie oder eine Kryptowährung in der Suchleiste an, um eine Zusammenfassung zu erhalten
Sihuan Pharmaceutical Holdings Group Ltd
0460Sihuan Pharmaceutical Holdings Group Ltd., an investment holding company, engages in the research and development, manufacture, marketing, and sale of pharmaceutical and medical aesthetic products in the People's Republic of China. The company operates through three segments: Medical Aesthetic Products, Innovative Medicine and Other Medicine, and Generic Medicine. It offers filling, shaping, supporting, supplementing, optoelectronic device, body sculpturing, skin care, and others, as well as non- or minimally invasive medical aesthetics comprehensive solutions. It offers drugs in the oncology, metabolism, diabetes, cardiovascular and cerebrovascular, modern Chinese medicine, and industrial hemp therapeutic areas. The company is also involved in the investment and sale of medical beauty products; manufacture of medical instruments; investment in properties; construction for medical projects; and project preparation for pharmaceutical products manufacturing. In addition, it provides information support, general hospital, hospital management, and biotechnology and technology promotion services. Sihuan Pharmaceutical Holdings Group Ltd. was founded in 2001 and is based in Wan Chai, Hong Kong. Address: Office Tower, Convention Plaza, Wan Chai, Hong Kong
Analytics
Zielpreis von Wall Street
21.33 HKDKGV
–Dividendenrendite
3.14 %Laufendes Jahr
Letztes Jahr
Laufendes Quartal
Letztes Quartal
Laufendes Jahr
Letztes Jahr
Laufendes Quartal
Letztes Quartal
Schlüsselzahlen 0460
Dividenden-Analyse 0460
Dividendenwachstum über 5 Jahre
76 %Kontinuierliches Wachstum
3 JahreAusschüttungsquote 5-Jahres-Durchschnitt
-108 %Verlauf der Dividende 0460
Bewertung der Aktie 0460
Finanzen 0460
Ergebnisse | 2019 | Dynamik |